Coronavirus delays Biogen's Spinraza for some patients

U.S. drugmaker Biogen Inc said on Wednesday that some patients on its drug Spinraza - which treats a rare disorder called spinal muscular atrophy (SMA) - are having their treatments postponed to prioritize COVID-19 patients.

from Reuters: Health News https://ift.tt/2x4fJIC
via IFTTT